Stem cell treatment is no longer considered purely experimental in the field of fertility treatments. With numerous studies showcasing promising results, it is becoming a viable option for cases that previously seemed beyond hope.
Tuberculosis (TB) is widespread, especially in India. Although TB primarily affects the lungs, it can also target reproductive organs, leading to significant damage. When a woman suffers from genital TB, it often results in irreversible damage to the fallopian tubes and, in more severe cases, the endometrium.
Ovarian reserve, or the number of eggs a woman has, naturally declines with age, particularly after 35. In some cases, this decline begins prematurely, even in women as young as 30. Until recently, there was no way to reverse this process.
PRP is derived from the patient’s own blood. After blood is collected, it is processed to isolate the stem cells, which are then used in the treatment.
Stem cells can also be harvested from the patient’s bone marrow. Both PRP and bone marrow-derived cells are autologous, meaning they come from the patient’s own body, significantly reducing the risk of infection, rejection, or adverse reactions.
While stem cell therapy holds significant promise, it is still in its early stages of development. Though results have been encouraging, it is important to maintain realistic expectations. Stem cell therapy can be considered when other options like surrogacy or egg donation are either not feasible or acceptable to the couple. Although it may not guarantee miraculous results, it provides a viable option when no other solutions seem available, and it poses no harm to the patient.
At KIC Delfinium Fertility Centre, we are dedicated to exploring every possible avenue to help couples achieve their dream of parenthood. Stem cell therapy may be the solution you’re looking for, especially when faced with challenges like poor ovarian reserve or endometrial damage. Get in touch with us at +91 95997 54455 or email us at info@kicdelfinium.com.